
【レポートの概要(一部)】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Myocardial Ischemia Overview 8
Therapeutics Development 9
Pipeline Products for Myocardial Ischemia – Overview 9
Pipeline Products for Myocardial Ischemia – Comparative Analysis 10
Myocardial Ischemia – Therapeutics under Development by Companies 11
Myocardial Ischemia – Therapeutics under Investigation by Universities/Institutes 12
Myocardial Ischemia – Pipeline Products Glance 13
Late Stage Products 13
Clinical Stage Products 14
Early Stage Products 15
Myocardial Ischemia – Products under Development by Companies 16
Myocardial Ischemia – Products under Investigation by Universities/Institutes 18
Myocardial Ischemia – Companies Involved in Therapeutics Development 19
Baxter International Inc. 19
CoDa Therapeutics, Inc. 20
Lixte Biotechnology Holdings, Inc. 21
Miltenyi Biotec GmbH 22
Nyken BV 23
Opsona Therapeutics Ltd. 24
Taxus Cardium Pharmaceuticals Group Inc. 25
ViroMed Co., Ltd. 26
Myocardial Ischemia – Therapeutics Assessment 27
Assessment by Monotherapy Products 27
Assessment by Target 28
Assessment by Mechanism of Action 30
Assessment by Route of Administration 32
Assessment by Molecule Type 34
Drug Profiles 36
alferminogene tadenovec – Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
AntimiR-199a – Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
EP-80317 – Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
Gene Therapy for Ischemic Heart Failure – Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
Humanin – Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
LB-100 – Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
LB-102 – Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
MG-53 – Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
NYK-1112 – Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
OPN-305 – Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
Peptagon – Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
PMC-6 – Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
Protein for Myocardial Infarction and Critical Limb Ischemia – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
Recombinant Peptide to Activate FPR2 for Ischemia Reperfusion Injury and Myocardial Ischaemia – Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
Recombinant Protein to Inhibit CXCL for Cardiovascular and Immunology – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
Small Molecule to Inhibit Arginase-1 and Arginase-2 for Myocardial Ischemia and Ischemia Reperfusion Injury – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
Small Molecules to Activate Heat Shock Protein H11 Kinase for Myocardial Ischemia – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
Small Molecules to Antagonize TRPM7 for Myocardial Ischemia and Glaucoma – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
Small Molecules to Inhibit Mst1 for Myocardial Ischemia – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
Stem Cell Therapy for Cardiovascular Disease – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
Stem Cell Therapy for Cardiovascular Diseases – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
VM-202 – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
Myocardial Ischemia – Recent Pipeline Updates 63
Myocardial Ischemia – Dormant Projects 69
Myocardial Ischemia – Product Development Milestones 70
Featured News & Press Releases 70
Jan 27, 2015: Taxus Cardium Announces Scientific Presentation And Clinical Update On Phase 3 Angiogenic Gene Therapy At The 2015 Phacilitate 11th Annual Cell & Gene Therapy Forum 70
Sep 03, 2014: Taxus Cardium to Present at the Rodman & Renshaw 16th Annual Global Investment Conference in New York City 72
Aug 13, 2014: Taxus Cardium Announces Biological and Clinical Advances in Angiogenic Gene Therapy for Heart Disease in Journal of Cardiovascular Pharmacology 73
Jun 12, 2014: Cardium To Announce Interim Results Of Generx Angiogenic Gene Therapy Phase 3 Clinical Study At The 2014 BIO International Convention 73
Jan 27, 2014: Cardium Announces Strategic Focus On Advanced Regenerative Therapeutics Based On Generx Clinical Findings 74
May 02, 2013: Cardium Therapeutics Announces Publication Of Data On Generx In Journal Molecular Therapy 75
Nov 19, 2012: Cardium Therapeutics Announces Patent Award For Rights To Cardiovascular Gene Therapy For Treatment Of Heart Disease 76
Oct 25, 2012: Cytori Announces Japanese Approval For Clinical Studies Of Cardiovascular And Chronic Liver Disease Cell Therapy 78
May 18, 2012: New drug discovery collaborations with Queen Mary University of London launched 78
Mar 20, 2012: Cardium Therapeutics Initiates Generx Phase III Clinical Registration Study 79
Appendix 81
Methodology 81
Coverage 81
Secondary Research 81
Primary Research 81
Expert Panel Validation 81
Contact Us 81
Disclaimer 82
【レポート販売概要】
■ タイトル:心筋虚血(Myocardial Ischemia):治療薬開発パイプライン動向(2015年上半期版)■ 英文:Myocardial Ischemia - Pipeline Review, H1 2015
■ 発行日:2015年2月24日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6276IDB
■ 調査対象地域:グローバル
- アメリカのSSL証明書市場2016-2020About the Secured Socket Layer (SSL) Certification Market in the US SSL is a paradigm technology for the secure transmission of data between a client (web browser) and a server (web server). • SSL creates an encrypted link between a web browser and a web server, which allows secure data transmission. • It is a security protocol that uses algorithms to determine variables of the encryption for both …
- インフルエンザ:グローバル臨床試験レビューH2, 2013Influenza Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Influenza Global Clinical Trials Review, H2, 2013" provides data on the Influenza clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Influenza. It includes an overview of the trial numbers and their recruitment status as per the site of trial c …
- 民間ヘリコプターの世界市場2016-2026Visiongain assesses that the civil helicopter market is valued at $7,876m in 2016. Civil helicopters offer a number of capabilities that cannot be achieved with fixed wing aircraft. Vertical take-off and landing capabilities mean that helicopters can operate in areas that are remote, have difficult terrain characteristics or where ground transport infrastructure or airfield facilities are under-de …
- 飲料包装機械の世界市場2017-2021About Beverage Packaging MachineryPackaging machinery is used to pack products before dispatch to the distribution networks. Many industries, such as food and beverages, pharmaceuticals, personal care products, and others, utilize packaging products and services. Packaging also plays an important role in the marketing mix as it has an impact on the buying decisions of consumers. Packaging machiner …
- 超小型LEDの世界市場予測(~2025年):LEDディスプレイパネル、LED照明機器The micro-LED market is estimated to be USD 254.1 Million in 2017 and is likely to reach USD 19,921.3 Million by 2025, at CAGR of 54.7% between 2019 and 2025. Increasing demand for brighter and more power efficient display panels for several applications is the main driver of the market. The market is also driven by factors such as increase in applications, high adoption rate of near-to-eye (NTE) …
- ICT投資の優先順位:製造産業部門 – 企業のICT投資計画Why was the report written? In order to provide deeper insights into manufacturers’ ICT investment priorities and strategic objectives. What is the current market landscape and what is changing? Cloud computing is currently receiving lower investments in the manufacturing sector. However, Kable believes that spending on cloud computing is set to witness an upward momentum in the coming months. Wha …
- 二輪車用スパークプラグの世界市場2017-2021About Two-Wheeler Spark PlugsA spark plug is a device used to transfer electric current to the combustion chamber to ignite the air-fuel mixture with an electric spark. Technavio’s analysts forecast the global two-wheeler spark plugs market to grow at a CAGR of 6.49% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global …
- 経皮吸収パッチの世界市場及びパイプラインインサイトTechnological progress is continuously increasing allowing pharmaceutical companies to develop newer products with higher pharmacological benefits. Transdermal patches are extension of their continuous efforts due to which several patients have been able to improve quality of life. This market segment has yet to be tapped as only few disease indications are being covered under their treatment. Pha …
- シクロヘキサン(CX)の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world cyclohexane market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true insig …
- スクラレオールの世界市場2015Sclareol (CAS 515-03-7) Market Research Report 2015 aims at providing comprehensive data on Sclareol market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Sclareol description, covers its application areas, manufacturing methods, patterns. It captures Sclareol market trends, pays close attention to Sclareol manufacturers and names suppliers. Besides, …
- 世界の主要超音波診断装置(医療機器)メーカー分析2014Complete report $12,500. Individual company assessments $1,850. The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. This unique study is designed to provide diagnostic imaging industry executives with strategically significant competitor information, analysis and insight crucial to the development and im …
- グローバル及び地域メガトレンド:「バリュー(価値)」における消費者態度及び行動の理解Summary Global and Regional Mega-Trends: Understanding Consumer Attitudes and Behaviors in Value' examines how attitudes to value when buying groceries are changing and the impact this is having on shopping habits and levels of loyalty towards both brands and retailers. The report examines new ways in which manufacturers can look to provide maximum value added for consumers as they become fatigued …
- 世界のエラストマー市場2015The Global Elastomers Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Elastomers industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Elastomers market analysis is provided for the international markets including development trends, competitive lands …
- バイオサーファクタント(天然由来界面活性剤)の世界市場:MES/APG/ソルビタンエステル/ショ糖エステル/ラムノリピド・バイオサーファクタントAbout Bio-Surfactants Bio-surfactants are an assorted gathering of active molecules that can be produced by integrating living cells or micro-organisms, such as bacteria, fungi, and yeast. Bio-based surfactants can be produced from oleochemical raw materials such as vegetable oils, animal fats, sucrose, and glucose. Due to their excellent foaming, wetting, emulsifying, and detergency traits, bio-s …
- MV Oil Trust:石油・ガスの開発・生産動向及びコスト分析– Q4, 2012MV Oil Trust Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary MV Oil Trust Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operation …